SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-07-028179
Filing Date
2007-04-13
Accepted
2007-04-13 12:29:04
Documents
7
Period of Report
2007-05-23
Effectiveness Date
2007-04-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A a07-9297_1def14a.htm DEF 14A 1258026
2 GRAPHIC g92971dui001.gif GRAPHIC 3097
3 GRAPHIC g92971dui002.gif GRAPHIC 9471
4 GRAPHIC g92971bci001.gif GRAPHIC 3117
5 GRAPHIC g92971bci002.gif GRAPHIC 2486
6 GRAPHIC g92971ds09i001.gif GRAPHIC 2486
7 GRAPHIC g92971bei001.gif GRAPHIC 2486
  Complete submission text file 0001104659-07-028179.txt   1292271
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19700 | Film No.: 07765168
SIC: 2834 Pharmaceutical Preparations